Germline EGFR T790M mutation and lung cancer risk
Science · 2026
DOI: 10.1126/science.aec0473 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science, 2026. Verfasst von Jaclyn LoPiccolo und 26 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Hauptthemen laut MEDLINE: ErbB Receptors, Germ-Line Mutation, Lung Neoplasms. Die Arbeit nennt 79 Literaturangaben.
Abstract (Originalsprache)
Most lung cancers are tobacco related, with genetic factors influencing smoking behavior identified through genome-wide association studies. However, inherited risk in familial and non-smoking-related lung cancers, including risk in carriers of EGFR T790M, remains poorly understood. Here, in more than 3.3 million individuals, the EGFR T790M germline variant is significantly associated with lung cancer risk, with no increased risk for 17 other cancers and no interaction with polygenic risk. This risk exceeds that conferred by smoking and is several-fold higher in never-smokers. Global geographic and ancestry analyses show higher T790M prevalence in the US than in British- and Irish-descendant populations, reflecting a Southern Appalachian founder event about 200 to 225 years ago, increasing regional prevalence and affecting those of British, Irish, and African descent. Recognition of high-risk carriers may inform targeted genetic testing and screening strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
- The Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
- 23andMe Research Institute, Palo Alto, CA, USA.
- Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA, USA.
- The Eli and Edythe L. Broad Institute, Cambridge, MA, USA.
- Addario Lung Cancer Medical Institute, San Carlos, CA, USA.
ORCID-Profile: Jaclyn LoPiccolo, Steven Micheletti, Jing Shi, Wei Wang, Pierre Fontanillas, Diane R Koeller, Helen Yatzus, Jose A Avila, Raphael B Liautaud, Allison Harper, Virginia Kotait, Ericka Izzo, Andrew Ciupek, Courtney A Granville, Ryan L Collins, Judy E Garber, David C Christiani, Alexander Gusev, Pasi A Jänne
Zitieren
APA
LoPiccolo, J., Micheletti, S., Shi, J., Wang, W., Saini, S., Lin, K. H., Xu, W., Fontanillas, P., 23andMe Research Team3‡, Koeller, D. R., Yatzus, H., Williamson, V. G., Avila, J. A., Liautaud, R. B., Fields, N. D., Harper, A., Kotait, V., Izzo, E., Ciupek, A., …, & Jänne, P. A. (2026). Germline EGFR T790M mutation and lung cancer risk. Science. https://doi.org/10.1126/science.aec0473
Vancouver
LoPiccolo J, Micheletti S, Shi J, Wang W, Saini S, Lin KH, et al. Germline EGFR T790M mutation and lung cancer risk. Science. 2026. doi:10.1126/science.aec0473
BibTeX
@article{LoPiccolo2026,
author = {LoPiccolo, Jaclyn and Micheletti, Steven and Shi, Jing and Wang, Wei and Saini, Shubham and Lin, Keng-Han and Xu, Wanwan and Fontanillas, Pierre and 23andMe Research Team3‡, 23andMe Research Team3‡ and Koeller, Diane R and Yatzus, Helen and Williamson, Victoria G and Avila, Jose A and Liautaud, Raphael B and Fields, Noah D and Harper, Allison and Kotait, Virginia and Izzo, Ericka and Ciupek, Andrew and Granville, Courtney A and Collins, Ryan L and Garber, Judy E and Christiani, David C and Aslibekyan, Stella and Granka, Julie M and Gusev, Alexander and Jänne, Pasi A},
title = {Germline EGFR T790M mutation and lung cancer risk},
journal = {Science},
year = {2026},
doi = {10.1126/science.aec0473}
}
EUVIMED